Company intelligence / Profile preview
AlphaVax, Inc.
Durham, North Carolina, United Statesalphavax.com ↗
- Ownership
- Private
- Employees
- ~70
- Development stage
- Other
01
Overview
Four alphavaccine candidates (targeting human cytomegalovirus, influenza A virus, prostate cancer and HIV-1) have been evaluated in five Phase 1 clinical trials. Results from their first trial evaluating CEA alphavaccine in patients with Stage IV colon cancer showed the vector technology was able to "break self-tolerance" with a reported trend for enhanced survival in patients with CEA-specific T cell responses. The company has completed clinical trials in breast cancer and gastrointestinal cancers (in Stage III patients).
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- RNA vaccinesself-amplifying RNA vaccines (saRNA)alphavaccine vector technology
- Industry
- Biotech
02
Drug pipeline
24 assets23 more assets in the full pipeline.
03
Partnerships
Novartis Vaccines and Diagnostics, Inc. (for CMV)US government agenciesDepartment of Defense
Beyond the preview
Go deeper on AlphaVax, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AlphaVax, Inc..